Drug Approval | June 22, 2023
Lupin receives USFDA approval for Tiotropium Dry Powder Inhaler
This product will be manufactured at Lupin's Pithampur facility in India
This product will be manufactured at Lupin's Pithampur facility in India
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
He will continue to lead business in LATAM and Asia regions in this new role
Subscribe To Our Newsletter & Stay Updated
